Enhertu

SOUTH SAN FRANCISCO, Calif., Aug. 15, 2022 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., (“ALX Oncology”) (Nasdaq: ALXO) a clinical-stage immuno-oncology company developing therapies…

You're reading Entrepreneur United States, an international franchise of Entrepreneur Media. This story originally appeared on Zacks AstraZeneca’s AZN stock rose…

The recently approved antibody-drug conjugate trastuzumab deruxtecan (T-DXd; Enhertu) was clearly more…